UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 26, 2015
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 001-36743
Apple Inc.
(Exact name of Registrant as specified in its charter)
California
94-2404110
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Infinite Loop
Cupertino, California
95014
(Address of principal executive offices)
(Zip Code)
(408) 996-1010
(Registrant s telephone number, including area code)
Indicate by check mark whether
the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File
required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).
Yes No
Indicate by check mark whether the Registrant is a
large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2
of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes No
5,544,583,000 shares of common stock, par value $0.00001
per share, issued and outstanding as of January 8, 2016
Table of Contents
Apple Inc.
Form 10-Q
For the Fiscal Quarter Ended
December 26, 2015
TABLE OF CONTENTS
Page
Part I
Item 1.
Financial Statements
Item 2.
Management s Discussion and Analysis of Financial Condition and Results of Operations
22
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
32
Item 4.
Controls and Procedures
32
Part II
Item 1.
Legal Proceedings
33
Item 1A.
Risk Factors
34
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
44
Item 3.
Defaults Upon Senior Securities
44
Item 4.
Mine Safety Disclosures
44
Item 5.
Other Information
44
Item 6.
Exhibits
45
Table of Contents
PART I FINANCIAL INFORMATION
Item 1.
Financial Statements
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(In millions, except number of shares which are reflected in thousands and per share amounts)
Three Months Ended
December 26, 2015
December 27, 2014
Net sales
75,872
74,599
Cost of sales
45,449
44,858
Gross margin
30,423
29,741
Operating expenses:
Research and development
2,404
1,895
Selling, general and administrative
3,848
3,600
Total operating expenses
6,252
5,495
Operating income
24,171
24,246
Other income/(expense), net
402
170
Income before provision for income taxes
24,573
24,416
Provision for income taxes
6,212
6,392
Net income
18,361
18,024
Earnings per share:
Basic
3.30
3.08
Diluted
3.28
3.06
Shares used in computing earnings per share:
Basic
5,558,930
5,843,082
Diluted
5,594,127
5,881,803
Cash dividends declared per share
0.52
0.47
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(In millions)
Three Months Ended
December 26, 2015
December 27, 2014
Net income
18,361
18,024
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax
(102
(66
Change in unrealized gains/losses on derivative instruments:
Change in fair value of derivatives, net of tax
287
1,982
Adjustment for net (gains)/losses realized and included in net income, net of tax
(445
(565
Total change in unrealized gains/losses on derivative instruments, net of tax
(158
1,417
Change in unrealized gains/losses on marketable securities:
Change in fair value of marketable securities, net of tax
(922
(456
Adjustment for net (gains)/losses realized and included in net income, net of tax
47
(14
Total change in unrealized gains/losses on marketable securities, net of tax
(875
(470
Total other comprehensive income/(loss)
(1,135
881
Total comprehensive income
17,226
18,905
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
Apple Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In millions, except number of shares which are reflected in thousands and par value)
December 26, 2015
September 26, 2015
ASSETS:
Current assets:
Cash and cash equivalents
16,689
21,120
Short-term marketable securities
21,385
20,481
Accounts receivable, less allowances of $63 in each period
12,953
16,849
Inventories
2,451
2,349
Vendor non-trade receivables
11,668
13,494
Other current assets
11,073
15,085
Total current assets
76,219
89,378
Long-term marketable securities
177,665
164,065
Property, plant and equipment, net
22,300
22,471
Goodwill
5,202
5,116
Acquired intangible assets, net
3,924
3,893
Other non-current assets
7,974
5,556
Total assets
293,284
290,479
LIABILITIES AND SHAREHOLDERS EQUITY:
Current liabilities:
Accounts payable
33,312
35,490
Accrued expenses
24,032
25,181
Deferred revenue
8,989
8,940
Commercial paper
7,259
8,499
Current portion of long-term debt
2,500
2,500
Total current liabilities
76,092
80,610
Deferred revenue, non-current
3,546
3,624
Long-term debt
53,204
53,463
Other non-current liabilities
32,175
33,427
Total liabilities
165,017
171,124
Commitments and contingencies
Shareholders equity:
Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 5,544,487 and 5,578,753 shares issued and
outstanding, respectively
28,253
27,416
Retained earnings
101,494
92,284
Accumulated other comprehensive income/(loss)
(1,480
(345
Total shareholders equity
128,267
119,355
Total liabilities and shareholders equity
293,284
290,479
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(In millions)
Three Months Ended
December 26, 2015
December 27, 2014
Cash and cash equivalents, beginning of the period
21,120
13,844
Operating activities:
Net income
18,361
18,024
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
2,954
2,575
Share-based compensation expense
1,078
888
Deferred income tax expense
1,592
2,197
Changes in operating assets and liabilities:
Accounts receivable, net
3,896
751
Inventories
(102
(172
Vendor non-trade receivables
1,826
(3,508
Other current and non-current assets
(893
(1,648
Accounts payable
(852
9,003
Deferred revenue
(29
945
Other current and non-current liabilities
(368
4,667
Cash generated by operating activities
27,463
33,722
Investing activities:
Purchases of marketable securities
(47,836
(44,915
Proceeds from maturities of marketable securities
3,514
2,807
Proceeds from sales of marketable securities
28,262
24,166
Payments made in connection with business acquisitions, net
(86
(23
Payments for acquisition of property, plant and equipment
(3,612
(3,217
Payments for acquisition of intangible assets
(394
(48
Other
(298
65
Cash used in investing activities
(20,450
(21,165
Financing activities:
Proceeds from issuance of common stock
80
Excess tax benefits from equity awards
224
264
Payments for taxes related to net share settlement of equity awards
(597
(512
Payments for dividends and dividend equivalents
(2,969
(2,801
Repurchase of common stock
(6,863
(5,030
Proceeds from issuance of term debt, net
3,485
Change in commercial paper, net
(1,240
(2,409
Cash used in financing activities
(11,444
(6,923
Increase/(decrease) in cash and cash equivalents
(4,431
5,634
Cash and cash equivalents, end of the period
16,689
19,478
Supplemental cash flow disclosure:
Cash paid for income taxes, net
3,398
3,869
Cash paid for interest
396
202
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Summary of Significant Accounting Policies
Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs, manufactures and
markets mobile communication and media devices, personal computers and portable digital music players, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications. The Company
sells its products worldwide through its retail stores, online stores and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the Company sells a variety of
third-party Apple-compatible products, including application software and various accessories through its online and retail stores. The Company sells to consumers, small and mid-sized businesses and education, enterprise and government customers.
Basis of Presentation and Preparation
The accompanying
condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. In the opinion of the Company s management, the condensed consolidated financial statements reflect
all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles
( GAAP ) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.
Certain prior period amounts in the condensed consolidated financial statements have been reclassified to conform to the current period s presentation.
These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated
financial statements and the notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 26, 2015 (the 2015 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the
last Saturday of September. An additional week is included in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company s fiscal years 2016 and 2015 each include 52 weeks. Unless
otherwise stated, references to particular years, quarters or months refer to the Company s fiscal years ended in September and the associated quarters or months of those fiscal years.
During the first quarter of 2016, the Company adopted an accounting standard that simplified the presentation of deferred taxes by requiring deferred tax
assets and liabilities be classified as noncurrent in a classified statement of financial position. The Company has adopted this accounting standard prospectively; accordingly, the prior period amounts in the Company s Condensed
Consolidated Balance Sheets within this Quarterly Report on Form 10-Q were not adjusted to conform to the new accounting standard. The adoption of this accounting standard was not material to the Company s condensed consolidated financial
statements.
Table of Contents
Earnings Per Share
Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock
outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of
additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company s employee
stock purchase plan, unvested restricted stock and unvested restricted stock units ( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method.
Under the treasury stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive effect from potentially dilutive securities.
The following table shows the computation of basic and diluted earnings per share for the three months ended December 26, 2015 and December 27,
2014 (net income in millions and shares in thousands):
Three Months Ended
December 26, 2015
December 27, 2014
Numerator:
Net income
18,361
18,024
Denominator:
Weighted-average shares outstanding
5,558,930
5,843,082
Effect of dilutive securities
35,197
38,721
Weighted-average diluted shares
5,594,127
5,881,803
Basic earnings per share
3.30
3.08
Diluted earnings per share
3.28
3.06
Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted
earnings per share.
Note 2 Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company s cash and available-for-sale
securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of December 26, 2015 and
September 26, 2015 (in millions):
December 26, 2015
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
11,152
11,152
11,152
Level 1 (1):
Money market funds
3,517
3,517
3,517
Mutual funds
1,772
(206
1,566
1,566
Subtotal
5,289
(206
5,083
3,517
1,566
Level 2 (2):
U.S. Treasury securities
40,739
43
(108
40,674
203
1,602
38,869
U.S. agency securities
5,307
(10
5,299
469
865
3,965
Non-U.S. government securities
6,530
31
(201
6,360
454
5,906
Certificates of deposit and time deposits
2,986
2,986
258
1,424
1,304
Commercial paper
2,236
2,236
1,089
895
252
Corporate securities
125,000
132
(1,684
123,448
14,463
108,984
Municipal securities
946
(1
948
28
920
Mortgage- and asset-backed securities
17,635
23
(105
17,553
88
17,465
Subtotal
201,379
234
(2,109
199,504
2,020
19,819
177,665
Total
217,820
234
(2,315
215,739
16,689
21,385
177,665
Table of Contents
September 26, 2015
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
11,389
11,389
11,389
Level 1 (1):
Money market funds
1,798
1,798
1,798
Mutual funds
1,772
(144
1,628
1,628
Subtotal
3,570
(144
3,426
1,798
1,628
Level 2 (2):
U.S. Treasury securities
34,902
181
(1
35,082
3,498
31,584
U.S. agency securities
5,864
14
5,878
841
767
4,270
Non-U.S. government securities
6,356
45
(167
6,234
43
135
6,056
Certificates of deposit and time deposits
4,347
4,347
2,065
1,405
877
Commercial paper
6,016
6,016
4,981
1,035
Corporate securities
116,908
242
(985
116,165
11,948
104,214
Municipal securities
947
952
48
904
Mortgage- and asset-backed securities
16,121
87
(31
16,177
17
16,160
Subtotal
191,461
574
(1,184
190,851
7,933
18,853
164,065
Total
206,420
574
(1,328
205,666
21,120
20,481
164,065
(1)
The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.
(2)
The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities,
quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons
including, but not limited to, anticipation of credit deterioration and duration management. The maturities of the Company s long-term marketable securities generally range from one to five years.
As of December 26, 2015, the Company considers the declines in market value of its marketable securities investment portfolio to be temporary in
nature and does not consider any of its investments other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy
generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment
for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates
and the Company s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment s cost basis.
Derivative Financial Instruments
The Company may use
derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company
may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than
a portion of the financial impact resulting from movements in foreign currency exchange or interest rates.
To help protect gross margins from
fluctuations in foreign currency exchange rates, certain of the Company s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not
the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company may enter into forward contracts, option contracts or other
instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12
months.
Table of Contents
To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange
rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. In addition, the Company may use
non-derivative financial instruments, such as its foreign currency-denominated debt, as economic hedges of its net investments in certain foreign subsidiaries. In both of these cases, the Company designates these instruments as net investment
hedges.
The Company may also enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses
generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies.
The Company may enter into interest rate
swaps, options, or other instruments to manage interest rate risk. These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company s term debt or investments. The Company designates these
instruments as either cash flow or fair value hedges. The Company s hedged interest rate transactions as of December 26, 2015 are expected to be recognized within nine years.
Cash Flow Hedges
The effective portions of cash flow hedges
are recorded in accumulated other comprehensive income ( AOCI ) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net
sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized.
Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. The ineffective portions and amounts excluded
from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net.
Derivative instruments designated as cash flow
hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such
derivative instruments are reclassified immediately into other income/(expense), net. Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other
transactions.
Net Investment Hedges
The effective
portions of net investment hedges are recorded in other comprehensive income ( OCI ) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges
are recognized in other income/(expense), net.
Fair Value Hedges
Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value
of the underlying hedged item.
Non-Designated Derivatives
Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the
derivative relates.
The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company s accounting
treatment for these derivative instruments is based on its hedge designation. The following tables show the Company s derivative instruments at gross fair value as of December 26, 2015 and September 26, 2015 (in millions):
December 26, 2015
Fair Value of
Derivatives
Designated as
Hedge Instruments
Fair Value of
Derivatives Not
Designated as
Hedge Instruments
Total
Fair Value
Derivative assets (1):
Foreign exchange contracts
1,021
275
1,296
Interest rate contracts
313
313
Derivative liabilities (2):
Foreign exchange contracts
877
157
1,034
Interest rate contracts
30
30
10
Table of Contents
September 26, 2015
Fair Value of
Derivatives
Designated as
Hedge Instruments
Fair Value of
Derivatives Not
Designated as
Hedge Instruments
Total
Fair Value
Derivative assets (1):
Foreign exchange contracts
1,442
109
1,551
Interest rate contracts
394
394
Derivative liabilities (2):
Foreign exchange contracts
905
94
999
Interest rate contracts
13
13
(1)
The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance
Sheets.
(2)
The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance
Sheets.
The following table shows the pre-tax gains and losses of the Company s derivative and non-derivative
instruments designated as cash flow, net investment and fair value hedges on OCI and the Condensed Consolidated Statements of Operations for the three months ended December 26, 2015 and December 27, 2014 (in millions):